These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1075 related items for PubMed ID: 16580691

  • 1. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 2. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells.
    Rahman KM, Aranha O, Glazyrin A, Chinni SR, Sarkar FH.
    Oncogene; 2000 Nov 23; 19(50):5764-71. PubMed ID: 11126363
    [Abstract] [Full Text] [Related]

  • 3. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer.
    Lanza-Jacoby S, Burd R, Rosato FE, McGuire K, Little J, Nougbilly N, Miller S.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6161-9. PubMed ID: 17062693
    [Abstract] [Full Text] [Related]

  • 4. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
    Zhang L, Lau YK, Xia W, Hortobagyi GN, Hung MC.
    Clin Cancer Res; 1999 Feb 15; 5(2):343-53. PubMed ID: 10037184
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane.
    Chang X, Firestone GL, Bjeldanes LF.
    Carcinogenesis; 2006 Mar 15; 27(3):541-50. PubMed ID: 16199440
    [Abstract] [Full Text] [Related]

  • 6. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S, Huang X, Lee CK, Liu B.
    Oncogene; 2010 Jul 22; 29(29):4225-36. PubMed ID: 20498641
    [Abstract] [Full Text] [Related]

  • 7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.
    Rahman KW, Sarkar FH.
    Cancer Res; 2005 Jan 01; 65(1):364-71. PubMed ID: 15665315
    [Abstract] [Full Text] [Related]

  • 9. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 10. HER2/neu antisense targeting of human breast carcinoma.
    Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N, Drebin JA.
    Oncogene; 2000 Dec 11; 19(53):6138-43. PubMed ID: 11156527
    [Abstract] [Full Text] [Related]

  • 11. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.
    Jin Y, Zou X, Feng X.
    Anticancer Drugs; 2010 Oct 11; 21(9):814-22. PubMed ID: 20724916
    [Abstract] [Full Text] [Related]

  • 12. Enhanced apoptotic effects of novel paclitaxel analogs on NCI/ADR-RES breast cancer cells.
    Yang LX, Zhu J, Wang HJ, Holton RA.
    Anticancer Res; 2003 Oct 11; 23(4):3295-301. PubMed ID: 12926066
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
    Shiu LY, Liang CH, Huang YS, Sheu HM, Kuo KW.
    Cell Biol Toxicol; 2008 Jan 11; 24(1):1-10. PubMed ID: 17885815
    [Abstract] [Full Text] [Related]

  • 14. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
    Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID.
    Breast Cancer Res Treat; 2005 Nov 11; 94(1):37-46. PubMed ID: 16142439
    [Abstract] [Full Text] [Related]

  • 15. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
    Witters LM, Witkoski A, Planas-Silva MD, Berger M, Viallet J, Lipton A.
    Oncol Rep; 2007 Feb 11; 17(2):465-9. PubMed ID: 17203189
    [Abstract] [Full Text] [Related]

  • 16. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
    Cheema SK, Gobin AS, Rhea R, Lopez-Berestein G, Newman RA, Mathur AB.
    Int J Pharm; 2007 Aug 16; 341(1-2):221-9. PubMed ID: 17499461
    [Abstract] [Full Text] [Related]

  • 17. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.
    Tuna M, Chavez-Reyes A, Tari AM.
    Oncogene; 2005 Feb 24; 24(9):1648-52. PubMed ID: 15674342
    [Abstract] [Full Text] [Related]

  • 18. Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
    Piechocki MP, Yoo GH, Dibbley SK, Lonardo F.
    Cancer Res; 2007 Jul 15; 67(14):6825-43. PubMed ID: 17638894
    [Abstract] [Full Text] [Related]

  • 19. The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells.
    Choi KH, Kim HK, Kim JH, Choi ES, Shin JA, Lee SO, Chintharlapalli S, Safe S, Abdelrahim M, Kong G, Choi HS, Jung JY, Cho HT, Cho NP, Cho SD.
    Eur J Cancer Prev; 2010 Mar 15; 19(2):153-9. PubMed ID: 19949342
    [Abstract] [Full Text] [Related]

  • 20. A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation.
    Agarwal C, Sharma Y, Zhao J, Agarwal R.
    Clin Cancer Res; 2000 Jul 15; 6(7):2921-30. PubMed ID: 10914742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.